SCHEMBL32688405

SCHEMBL32688405

N#Cc1c(SCc2nnn[nH]2)[nH]c(=O)c(C#N)c1-c1cccc(-c2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.41
▸ POLB P06746 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ TNF P01375 1/20 0.41
▸ NOD2 Q9HC29 1/20 0.41
▸ NOD1 Q9Y239 1/20 0.41
▸ ADORA1 P30542 2/20 0.37
▸ HSD11B1 P28845 8/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ GLA P06280 2/20 0.35
▸ GAA P10253 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ HSD11B2 P80365 1/20 0.34
▸ ACMSD Q8TDX5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688289 0.93 ADORA1 (0.40) MEN1POLBKMT2ATNFNOD2
SCHEMBL32688370 0.90 POLB (0.41) MEN1POLBKMT2AHSD11B1ALDH1A1
SCHEMBL32688136 0.89 HSD11B1 (0.41) MEN1POLBKMT2AHSD11B1ALDH1A1
SCHEMBL32688147 0.87 HSD11B1 (0.40) MEN1POLBKMT2ATNFNOD2
SCHEMBL32688292 0.86 HPGD (0.42) MEN1KMT2AADORA1ALDH1A1KDM4E
SCHEMBL32688008 0.85 MEN1 (0.42) MEN1POLBKMT2ATNFNOD2
SCHEMBL32688035 0.83 MEN1 (0.41) MEN1POLBKMT2AHSD11B1HSD11B2
SCHEMBL32688401 0.82 POLB (0.37) MEN1POLBKMT2ATNFNOD2
SCHEMBL32688166 0.81 HSD11B1 (0.41) MEN1KMT2AADORA1HSD11B1HSD11B2
SCHEMBL32688269 0.81 HSD11B1 (0.45) MEN1POLBKMT2AHSD11B1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK MEN1 4353/4885POLB 508/4885KMT2A 3400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback